Patients who are beginning therapy with vitamin B 12 need to be monitored for:

Vitamin B12 deficiency can cause megaloblastic anemia and can lead to leukopenia (reduced white blood cell count). Monitoring for leukopenia is therefore important during therapy with vitamin B12 supplements. Hypertensive crisis, hypokalemia, and thrombocytopenia are not associated with vitamin B12 supplementation.

Patients who are beginning therapy with vitamin B 12 need to be monitored for:

Vitamin B12 deficiency can cause megaloblastic anemia and can lead to leukopenia (reduced white blood cell count). Monitoring for leukopenia is therefore important during therapy with vitamin B12 supplements. Hypertensive crisis, hypokalemia, and thrombocytopenia are not associated with vitamin B12 supplementation.

Solved

Patients Who Are Beginning Therapy with Vitamin B₁₂need to Be

Question 22

Multiple Choice

Patients who are beginning therapy with vitamin B₁₂need to be monitored for:

A) Hypertensive crisis that may occur in the first 36 hours
B) Hypokalemia that occurs in the first 48 hours
C) Leukopenia that occurs at 1 to 3 weeks of therapy
D) Thrombocytopenia that may occur at any time in therapy

Correct Answer: